Professor Dominique Jacquet discusses the acquisition of Pharmasset by pharmaceutical giant Gilead, which is receiving a lot of attention these days because of the promising remdesivir, which might alleviate symptoms of COVID-19.
No transcript available.
POWERED BY BLUBRRY
